sequenom inc (SQNM:NASDAQ GS)
Executive Profile*
Paul V. Maier M.B.A.Chief Financial Officer, Sequenom Inc. |
| Age | Total Calculated Compensation | This person is connected to 41 board members in 4 different organizations across 8 different industries. See Board Relationships |
| 64 | $1,003,543 As of Fiscal Year 2012 |
Background*
Mr. Paul V. Maier, M.B.A. has been the Chief Financial Officer at Sequenom Inc. since June 2010. Mr. Maier has been an Independent Financial Consultant since February 2007. He has over 20 years of experience as a senior executive in biotechnology and pharmaceutical companies. He served as Chief Financial Officer and Senior Vice President at Organon Pharmaceuticals USA, Inc. He served as a Consultant from October 2009 to November 10, 2009 and Interim Chief Financial Officer ...
Corporate Headquarters*3595 John Hopkins CourtSan Diego, California 92121 United States Phone: 858-202-9000 Fax: 858-202-9001 Board Members Memberships*2000-2005 Former Director, Chairman of Audit Committee and Member of Nominating and Corporate Governance Committee 2007-Present Director, Chairman of Audit Committee, Member of Compensation Committee and Member of Governance Committee 2008-Present Director, Chairman of Audit Committee and Chairman of Compensation Committee 2008-Present Director, Chairman of Audit Committee, Member of Special Committee and Member of Finance & Transactions Committee 2012-Present Director, Member of Audit Committee and Member of Corporate Governance/Nominating Committee
Education*MBA Harvard University BS Pennsylvania State University
Other Affiliations* |
Annual Compensation*
Stock Options*
Total Compensation*
|
| Recently Viewed | |||
| SQNM:US | $4.22 USD | +0.03 |  |
COMPETITOR COMPENSATION
| Name | Position/ Company | Compensation |
| Barry G. Caldwell | Chief Executive Officer, President and Director STAAR Surgical Company | $458.4K |
| Joseph P. Caruso | Chairman, Chief Executive Officer and President Palomar Medical Technologies Inc. | $390.0K |
| Gary R. Maharaj | Chief Executive Officer, President and Director SurModics, Inc. | $475.0K |
| Gajus V. Worthington | Co-Founder, Chief Executive Officer, President and Director Fluidigm Corporation | $350.0K |
| Paul K. Wotton Ph.D. | Chief Executive Officer, President and Director Antares Pharma Inc. | $477.0K | Compensation as of Fiscal Year 2012. |
Post a JobJobs
- San Diego, CA | SequenomPosted: Jun 10
- San Diego, CA | SequenomPosted: Jun 11
- San Diego, CA | SequenomPosted: Jun 11
- San Diego, CA | SequenomPosted: Jun 11
Sponsored Financial Commentaries
Sponsored Links
To contact SEQUENOM INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
